We just received data on a new analyst forecast for $BLTE. Marc Goodman from Leerink Partners set a price target of 215.0 for BLTE.
To track analyst ratings and price targets for $BLTE, check out Quiver Quantitative's $BLTE forecast page.
Should you buy $BLTE?
Some analysts are better than others. To view the past performance of Leerink Partners, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$BLTE Price Targets
Multiple analysts have issued price targets for $BLTE recently. We have seen 6 analysts offer price targets for $BLTE in the last 6 months, with a median target of $239.5.
Here are some recent targets:
- Marc Goodman from Leerink Partners set a target price of $215.0 on 11/13/2026
- Yi Chen from HC Wainwright & Co. set a target price of $245.0 on 10/15/2026
- Graig Suvannavejh from Mizuho set a target price of $234.0 on 09/09/2026
- Whitney Ijem from Canaccord Genuity set a target price of $303.0 on 09/04/2026
- Judah Frommer from Morgan Stanley set a target price of $206.0 on 08/14/2026
- Steve Seedhouse from Cantor Fitzgerald set a target price of $270.0 on 08/14/2026
$BLTE Insider Trading Activity
$BLTE insiders have traded $BLTE stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.
Here’s a breakdown of recent trading of $BLTE stock by insiders over the last 6 months:
- YU-HSIN LIN (Chief Executive Officer) has made 0 purchases and 21 sales selling 100,800 shares for an estimated $19,148,375.
- HAO-YUAN CHUANG (Chief Financial Officer) has made 0 purchases and 21 sales selling 67,762 shares for an estimated $12,869,714.
- HENDRIK PETER SCHOLL (Chief Medical Officer) has made 0 purchases and 21 sales selling 20,500 shares for an estimated $2,940,823.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BLTE Hedge Fund Activity
We have seen 56 institutional investors add shares of $BLTE stock to their portfolio, and 40 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MAVERICK CAPITAL LTD added 396,311 shares (+inf%) to their portfolio in Q2 2026, for an estimated $61,025,949
- LOGOS GLOBAL MANAGEMENT LP added 250,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $38,496,250
- HOLOCENE ADVISORS, LP removed 243,460 shares (-49.2%) from their portfolio in Q2 2026, for an estimated $37,489,188
- PRICE T ROWE ASSOCIATES INC /MD/ removed 175,946 shares (-62.4%) from their portfolio in Q2 2026, for an estimated $27,093,044
- PERCEPTIVE ADVISORS LLC removed 151,979 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $23,402,486
- DEERFIELD MANAGEMENT COMPANY, L.P. added 123,386 shares (+52.8%) to their portfolio in Q2 2026, for an estimated $18,999,593
- BANK OF AMERICA CORP /DE/ added 121,005 shares (+3202.9%) to their portfolio in Q2 2026, for an estimated $18,632,954
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
